Analyst consensus rating
OptimizeRx Analyst Rating: Strong Buy
OPRX is rated Strong Buy by 5 analysts with a $12.40 target. As of 2026-08-28.
Direct answer
OptimizeRx's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $12.40.
Forecast evidence checked August 28, 2026.
Get free OptimizeRx email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $7.85
- Average price target
- $12.40
- High price target
- $18.00
- Low price target
- $10.00
- Low target gap
- +27.5%
- Target upside
- +58.1%
- High target gap
- +129.4%
- Target range width
- 102%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- August 28, 2026
- Valid through
- September 4, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for OptimizeRx?
OptimizeRx has a verified Strong Buy consensus. The same dataset has an average price target of $12.40.
How far are OptimizeRx's low and high targets from the recorded price?
The low target implies +27.5%, while the high target implies +129.4%.
How many analysts are included in OptimizeRx's consensus?
The verified consensus includes 5 analysts.
How is OptimizeRx's target upside or downside calculated?
The average target of $12.40 is divided by the recorded price of $7.85, then one is subtracted to produce +58.1%. This does not guarantee a future return.
When was OptimizeRx's analyst forecast verified?
The data was verified on 2026-08-28. The dataset is valid through 2026-09-04.